Evidence map›Paper›PMID 41211428›Full record

ArticleFrontiers in oncology2025

Primary cardiac lymphoma presenting as heart failure and atrioventricular block: case report.

Jiyi Liu, Fengzhi Sun, Sixun Jia, Shulong Zhang, Yu Wang

Abstract readCase Reports
In one paragraph

Article in Frontiers in oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Jiyi Liu *Heart Center, Affiliated Zhongshan Hospital of Dalian University, Dalian, China.
Fengzhi Sun *Heart Center, Affiliated Zhongshan Hospital of Dalian University, Dalian, China.
Sixun JiaHematology Center, Affiliated Zhongshan Hospital of Dalian University, Dalian, China.
Shulong ZhangHeart Center, Affiliated Zhongshan Hospital of Dalian University, Dalian, China.
Yu WangHeart Center, Affiliated Zhongshan Hospital of Dalian University, Dalian, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Primary cardiac lymphoma (PCL) is an extremely rare and highly aggressive malignancy that typically presents with nonspecific cardiac symptoms. We report a case of primary cardiac diffuse large B-cell lymphoma (DLBCL) with initial manifestations of heart failure and third-degree atrioventricular block. The patient presented with progressive dyspnea, palpitations, and unintentional weight loss. Transthoracic echocardiography revealed a large right atrial mass. The patient first underwent surgical resection of the cardiac tumor, and pathological examination confirmed non-GCB subtype DLBCL. During fractionated R-CHOP chemotherapy, the patient experienced cardiac arrest, necessitating the urgent implantation of a temporary pacemaker. Subsequently, a permanent pacemaker was implanted using a physiological pacing strategy. After six cycles of chemotherapy and ongoing pacing support, the patient achieved complete remission, with no evidence of tumor recurrence during the follow-up period. This case suggests that for PCL patients presenting with heart failure and third-degree atrioventricular block, a combination of surgical resection, fractionated R-CHOP chemotherapy, and physiological pacing may contribute to a favorable outcome.

Indexed as

atrioventricular blockcase reportdiffuse large B-cell lymphomaphysiological pacingprimary cardiac lymphoma

Identifiers

PMID41211428
PMCPMC12591941

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.